Cargando…
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells
SIMPLE SUMMARY: IgM monoclonal gammopathy of undetermined significance (IgM MGUS) is an early precursor stage of the rare lymphoma Waldenström Macroglobulinemia (WM). Although comparative gene expression studies on WM, IgM MGUS, and normal B-cells (CTRLs) identified several differentially expressed...
Autores principales: | Trojani, Alessandra, Di Camillo, Barbara, Bossi, Luca Emanuele, Leuzzi, Livia, Greco, Antonino, Tedeschi, Alessandra, Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Beghini, Alessandro, Cairoli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070603/ https://www.ncbi.nlm.nih.gov/pubmed/33921415 http://dx.doi.org/10.3390/cancers13081837 |
Ejemplares similares
-
Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018) -
Waldenström's macroglobulinemia front line treatment
por: Tedeschi, Alessandra, et al.
Publicado: (2019) -
Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance
por: Drandi, Daniela, et al.
Publicado: (2022) -
Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism
por: Jalali, Shahrzad, et al.
Publicado: (2021) -
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities
por: Frustaci, Anna Maria, et al.
Publicado: (2023)